Department of Graduate Studies in Biomedical Sciences, Federal University of Fronteira Sul (UFFS), Rodovia SC 484-Km 02, Fronteira Sul, Chapecó, SC, CEP 89815-899, Brazil.
Department of Medicine, Federal University of Fronteira Sul (UFFS), Chapecó, Santa Catarina, Brazil.
Purinergic Signal. 2024 Jun;20(3):213-222. doi: 10.1007/s11302-023-09950-1. Epub 2023 Jun 27.
The word sarcopenia derives from the Greek terms "sarx" for meat and "penia" for loss, thus being used to define reductions in muscle mass, muscle strength, and lower physical performance that compromise, mainly, the elderly population. Its high negative impact on patients' quality of life encourages the production and publication of new studies that seek to find methods to prevent and reverse cases of loss of muscle mass and strength. Furthermore, the high prevalence of sarcopenia in patients with chronic kidney disease (CKD) is closely related to its pathophysiology, which consists of a state of increased protein catabolism and decreased muscle tissue synthesis. Also considering the inflammatory nature of CKD and sarcopenia, the purinergic system has been an important target of studies, which seek to relate it to the two previous conditions. This system achieves anti-inflammatory action by inhibiting, through adenosine, pro-inflammatory factors such as interleukin-12 (IL-12), tumor necrosis factor alpha (TNF-α), and nitric oxide (NO), as well as by releasing anti-inflammatory substances such as interleukin-10 (IL-10). Simultaneously, the purinergic system presents pro-inflammatory activity, signaled by adenosine triphosphate (ATP), which occurs through the activation of T cells and the release of pro-inflammatory factors such as those mentioned above. Therefore, the ability of this system to act on inflammatory processes can promote positive and negative changes in the clinical aspect of patients with CKD and/or sarcopenia. Furthermore, it appears that there is a correlation between the practice of repeated physical exercise with the clinical improvement and in the quality of life of these patients, presenting a decrease in the levels of C-reactive protein (CRP), NTPDase, and the pro-inflammatory cytokine IL-6, such as increases in IL-10 resulting from modulation of the purinergic system. In this way, the present article seeks to evaluate the effect of physical exercise as a modulator of the purinergic system in the control of sarcopenia in patients with CKD on hemodialysis, in order to trace a relationship that can bring benefits both for biological markers and for quality of life of these patients.
肌少症一词源自希腊语“sarx”表示肉,“penia”表示损失,因此用于定义肌肉质量、肌肉力量和身体机能下降,主要影响老年人群。它对患者生活质量的负面影响很大,鼓励产生和发表新的研究,旨在寻找预防和逆转肌肉质量和力量损失的方法。此外,慢性肾脏病(CKD)患者肌少症的高患病率与它的病理生理学密切相关,其病理生理学包括蛋白质分解代谢增加和肌肉组织合成减少的状态。同时,考虑到 CKD 和肌少症的炎症性质,嘌呤能系统一直是研究的重要靶点,旨在将其与前两种情况联系起来。该系统通过腺苷抑制白细胞介素 12(IL-12)、肿瘤坏死因子-α(TNF-α)和一氧化氮(NO)等促炎因子,以及释放白细胞介素 10(IL-10)等抗炎物质,发挥抗炎作用。同时,嘌呤能系统通过三磷酸腺苷(ATP)信号传递表现出促炎活性,这是通过 T 细胞的激活和上述促炎因子的释放发生的。因此,该系统对炎症过程的作用能力可以促进 CKD 和/或肌少症患者临床方面的积极和消极变化。此外,似乎存在一种相关性,即反复进行身体锻炼与这些患者的临床改善和生活质量相关,表现为 C 反应蛋白(CRP)、NTPDase 和促炎细胞因子 IL-6 水平降低,以及 IL-10 水平升高,这是嘌呤能系统调节的结果。 因此,本文旨在评估身体锻炼作为调节 CKD 血液透析患者肌少症嘌呤能系统的一种方式的效果,以追踪一种可以为这些患者的生物标志物和生活质量带来益处的关系。